esophageal neoplasma
Showing 1 - 25 of 2,368
Esophagus Squamous Cell Carcinoma Trial in Huai'an (raltitrexed)
Active, not recruiting
- Esophagus Squamous Cell Carcinoma
-
Huai'an, Jiangsu, ChinaHuai'an First Hospital
Apr 5, 2021
Symptoms Based on Patient-reported Outcomes in Immunotherapy for
Not yet recruiting
- Esophageal Cancer
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 24, 2023
Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)
Not yet recruiting
- Esophagus Cancer
- Cadonilimab
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Nov 20, 2023
Azygos Vein Preservation Versus Disconnection, Tracheo-Esophageal Fistula With Atresia of Esophagus, Leak, Anastomotic Trial in
Completed
- Azygos Vein Preservation Versus Disconnection
- +4 more
- EA/TOF primary repair with Azygos vein preservation
- EA/TOF primary repair with Azygos vein sacrifice (disconnection)
-
Cairo, EgyptPediatric Surgery Department, Al-Azhar University
Jul 14, 2023
Esophageal Cancer Trial in Tianjin (Arm A, Arm B)
Not yet recruiting
- Esophageal Cancer
- Arm A
- Arm B
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital
Sep 24, 2023
Esophageal Tumors, Dysphagia Trial in São Paulo (Fully Covered Esophageal Prosthesis (FC-SEMS), Partially Covered Esophageal
Recruiting
- Esophageal Neoplasms
- Dysphagia
- Fully Covered Esophageal Prosthesis (FC-SEMS)
- Partially Covered Esophageal Prosthesis (PC-SEMS)
-
São Paulo, BrazilInstituto do Câncer do Estado de São Paulo
Oct 4, 2023
Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)
Enrolling by invitation
- Esophageal Carcinoma
- Nimotuzumab
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,
Recruiting
- The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
- Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
-
Hanzhou, Zhejiang, ChinaLulu Liu
Jul 14, 2023
Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)
Not yet recruiting
- Esophageal Carcinoma
- Neoadjuvant Therapy
- Toripalimab
- +3 more
- (no location specified)
Aug 16, 2023
Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)
Not yet recruiting
- Chemotherapy
- Radiation Therapy
- Camrelizumab
- +3 more
-
Fuzhou, ChinaFujian Medical University Union Hospital
Apr 6, 2023
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
- Radiotherapy
- Toripalimab
- (no location specified)
Mar 17, 2023
Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1
Recruiting
- Metastatic Esophageal Squamous Cell Carcinoma
- TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
-
Qingdao, Shandong, China
- +1 more
Nov 13, 2023
ARDS, Human, Obesity, Morbid Trial in France (Esophageal pressure-guided strategy,)
Not yet recruiting
- ARDS, Human
- Obesity, Morbid
- Esophageal pressure-guided strategy,
-
Angers, France
- +4 more
Nov 6, 2023
Esophageal and Gastric Varices Trial (Endoscopic gel embolization of gastric fundus varices and ligation of esophageal varices,
Not yet recruiting
- Esophageal and Gastric Varices
- Endoscopic gel embolization of gastric fundus varices and ligation of esophageal varices
- +2 more
- (no location specified)
Jul 31, 2023
Prevent Anastomotic Leakage After Esophagectomy Due to
Not yet recruiting
- Esophageal Cancer
- +2 more
- Eso-SPONGE®
-
Barcelona, Catalunya, SpainHospital Clinic de Barcelona
Oct 20, 2023
Gastroesophageal Reflux Trial in Milwaukee (Shaker Pressure Band)
Recruiting
- Gastroesophageal Reflux
- Shaker Pressure Band
-
Milwaukee, WisconsinMedical College of Wisconsin
Jan 13, 2023
Atrial Fibrillation Trial (E-SAFE)
Not yet recruiting
- Atrial Fibrillation
- E-SAFE
- (no location specified)
Oct 18, 2022
Esophageal and Gastric Varices Trial in Jinan (tongue diagnosis)
Active, not recruiting
- Esophageal and Gastric Varices
- tongue diagnosis
-
Jinan, Shandong, ChinaQilu Hospital of Shdong University
Aug 9, 2023
Atrial Fibrillation Trial in Chicago (Esophageal warming, Control)
Completed
- Atrial Fibrillation
- Esophageal warming
- Control
-
Chicago, IllinoisNorthwestern University
Feb 1, 2023
Peripheral Blood Neoantigen Specific T Cells Predict Efficacy of
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shanghai, Shanghai, ChinaCancer hospital Fudan University
Nov 30, 2022
Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab, Albumin paclitaxel, carboplatin AUC=5,
Recruiting
- Esophageal Squamous Cell Carcinoma
- Neoadjuvant Therapy
- Serplulimab, Albumin paclitaxel, carboplatin AUC=5, neoadjuvant therapy
- Esophagectomy
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 20, 2022
Atrial Fibrillation Trial in Iowa City (esophageal cooling device (Attune Medical, Chicago, IL))
Completed
- Atrial Fibrillation
- esophageal cooling device (Attune Medical, Chicago, IL)
-
Iowa City, IowaUniversity of Iowa
Sep 6, 2022
Esophageal Cancer Trial in Wuhan
Recruiting
- Esophageal Cancer
-
Wuhan, Hubei, ChinaRenmin hosptial of Wuhan University
Jun 7, 2023
Endoscopic Submucosal Dissection Versus Esophagectomy for Early
Completed
- Esophageal Cancer
- Endoscopic submucosal dissection
- Esophagectomy
-
Shanghai, ChinaChanghai Hospital, Naval Medical University
Sep 27, 2023
Esophageal Thermal Lesions in High-power-Short-duration Ablation
Recruiting
- Esophagus Injury
- Atrial Fibrillation
-
Leipzig, Saxony, Germany
- +1 more
Jan 24, 2023